← Back to news
NewsFRONTIERS IN IMMUNOLOGYFriday, April 10, 2026 · April 10, 2026

Breaking the metabolo-immune cycle in primary biliary cholangitis for therapeutic benefit.

WHY IT MATTERS

Recent peer-reviewed research on Primary biliary cholangitis that may be relevant for patients and caregivers.

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by cholestasis-driven bile duct injury and fibrosis. Biliary epithelial cells (BECs) play a central role in both bile homeostasis and immune regulation, and their metabolic and immune dysfunction is critical in PBC...

Read on PubMed
Read the original at Frontiers in immunology
ResearchPubMedPrimary biliary cholangitisHumansLiver Cirrhosis, Biliary

Related conditions

Primary biliary cholangitis

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.